Allen Nissenson insider trades: Angion Biomedica (ANGN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Allen reports to the SEC
Open-market buys and sales
13 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 20, 2022 | ANGN | ↑ Buy | 9,383 | $1.16 | $11K | Direct | May 23, 2022 (3d) |
| Feb 13, 2014 | DVA | ↓ Sell | 2,547 | $66.16 | $169K | Direct | Feb 18, 2014 (5d) |
| Dec 17, 2013 | DVA | ↓ Sell | 2,929 | $59.83 | $175K | Direct | Dec 18, 2013 (1d) |
| May 13, 2013 | DVA | ↓ Sell | 776 | $130.37 | $101K | Direct | May 15, 2013 (2d) |
| Mar 6, 2013 | DVA | ↓ Sell | 2,422 | $123.77 | $300K | Direct | Mar 8, 2013 (2d) |
| Nov 15, 2012 | DVA | ↓ Sell | 4,110 | $112.50 | $462K | Direct | Nov 16, 2012 (1d) |
| Aug 6, 2012 | DVA | ↓ Sell | 3,919 | $98.91 | $388K | Direct | Aug 8, 2012 (2d) |
| May 23, 2012 | DVA | ↓ Sell | 6,016 | $80.00 | $481K | Direct | May 25, 2012 (2d) |
| May 17, 2011 | DVA | ↓ Sell | 2,521 | $86.00 | $217K | Direct | May 19, 2011 (2d) |
| Feb 25, 2011 | DVA | ↓ Sell | 1,103 | $78.50 | $87K | Direct | Mar 1, 2011 (4d) |
| Nov 9, 2010 | DVA | ↓ Sell | 1,820 | $72.41 | $132K | Direct | Nov 12, 2010 (3d) |
| Jun 17, 2010 | DVA | ↓ Sell | 191 | $66.22 | $13K | Direct | Jun 21, 2010 (4d) |
| Mar 12, 2010 | DVA | ↓ Sell | 4,203 | $62.50 | $263K | Direct | Mar 16, 2010 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Allen Nissenson's insider trades
Allen Nissenson is a director at Angion Biomedica (ANGN). Since Mar 12, 2010, Allen has reported 1 open-market purchase worth $11K and 12 sales worth $2.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (18 filings), option exercises (13 filings), shares withheld for taxes (12 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.